The slow elimination of 1,4-bis [2-(3,5-dichloropyridyloxy)] benzene in mice leads to prolonged constitutive androstane receptor activation and hepatomegaly
Drug Metabolism and Disposition · 2025
DOI: 10.1016/j.dmd.2025.100092 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2025. Verfasst von Yue Gao und 9 weiteren Autor:innen. Beteiligte Einrichtung: NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening & Guangdong-Hongkong-M…. Hauptthemen laut MEDLINE: Hepatomegaly, Receptors, Cytoplasmic and Nuclear, Pyridines, Liver. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Shenzhen Science and Technology Innovation Program.
Abstract (Originalsprache)
Constitutive androstane receptor (CAR, NR1I3), a nuclear receptor superfamily member, plays a pivotal role in liver size regulation. Murine CAR agonist 1,4-bis [2-(3,5-dichloropyridyloxy)] benzene (TCPOBOP) was reported to induce hepatomegaly in mice, accompanied by hepatocyte hypertrophy and proliferation. However, whether CAR activation-induced hepatomegaly is reversible and the histological changes during the reversal process remain elusive. In the current study, C57BL/6 mice were administered TCPOBOP for 5 days and sacrificed at different time points after drug withdrawal. The results showed that TCPOBOP-induced hepatomegaly required a long time to reverse, as evidenced by the liver-to-body weight ratio in the TCPOBOP group remaining significantly higher than that in the vehicle group even 120 days after withdrawal. β-catenin and cyclin D1 staining indicated a reduction in hepatocyte size and proliferating cells. To investigate the involved mechanisms, we measured proteins associated with hepatomegaly and liver regeneration termination. The results suggested that yes-associated protein, C-MYC, β-catenin, forkhead box M1, and hepatocyte nuclear factor 4α changed significantly after TCPOBOP withdrawal and functioned at different stages during reversal. Furthermore, we established an ultra performance liquid chromatography-tandem mass spectrometry method to quantify TCPOBOP concentration. The results indicated a long-term hepatic retention of TCPOBOP, which constantly activated CAR and led to sustained hepatomegaly after TCPOBOP withdrawal. Overall, these findings revealed the reversibility of CAR activation-induced hepatomegaly and provided new insights into the safety of CAR as a drug target. Additionally, the results highlighted the importance of considering long-term TCPOBOP accumulation in the liver to avoid potential adverse effects and experimental biases. SIGNIFICANCE STATEMENT: This study demonstrated that hepatic retention of 1,4-bis [2-(3,5-dichloropyridyloxy)] benzene (TCPOBOP) is the fundamental cause of constant constitutive androstane receptor (CAR) activation and sustained hepatomegaly after drug withdrawal, which provided new data for the safety of CAR as a drug target and offered novel insights for CAR manipulation on liver diseases. Notably, when using TCPOBOP as a murine CAR agonist, attention should be paid to its hepatic accumulation and retention to avoid potential experimental biases and adverse effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening & Guangdong-Hongkong-Macao Joint Laboratory for New Drug Screening, School of Pharmaceutical…
- Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, China.
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Shenzhen Science and Technology Innovation Program
- Basic and Applied Basic Research Foundation of Guangdong Province
- China Postdoctoral Science Foundation
- National Postdoctoral Program for Innovative Talents
- Guangdong Provincial Medical Research Foundation
- Guangdong Provincial Pearl River Talents Program
Zitieren
APA
Gao, Y., Cai, C., Zheng, W., Fan, S., Zhang, Y., Zhou, Y., Li, H., Yang, J., Guan, S., & Bi, H. (2025). The slow elimination of 1,4-bis [2-(3,5-dichloropyridyloxy)] benzene in mice leads to prolonged constitutive androstane receptor activation and hepatomegaly. Drug Metabolism and Disposition. https://doi.org/10.1016/j.dmd.2025.100092
Vancouver
Gao Y, Cai C, Zheng W, Fan S, Zhang Y, Zhou Y, et al. The slow elimination of 1,4-bis [2-(3,5-dichloropyridyloxy)] benzene in mice leads to prolonged constitutive androstane receptor activation and hepatomegaly. Drug Metabolism and Disposition. 2025. doi:10.1016/j.dmd.2025.100092
BibTeX
@article{Gao2025,
author = {Gao, Yue and Cai, Chenghui and Zheng, Wanyu and Fan, Shicheng and Zhang, Yifei and Zhou, Yanying and Li, Huilin and Yang, Jie and Guan, Shaoxing and Bi, Huichang},
title = {The slow elimination of 1,4-bis [2-(3,5-dichloropyridyloxy)] benzene in mice leads to prolonged constitutive androstane receptor activation and hepatomegaly},
journal = {Drug Metabolism and Disposition},
year = {2025},
doi = {10.1016/j.dmd.2025.100092}
}
EUVIMED